Teus van Laar Selected Research

Teus van Laar Research Topics

Disease

53	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2003
6	Dementia (Dementias) 01/2022 - 12/2004
6	Dyskinesias (Dyskinesia) 10/2021 - 04/2008
5	Hallucinations (Hallucination) 06/2018 - 09/2009
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 12/2004
3	Cognitive Dysfunction 01/2022 - 12/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2019
2	Dystonia (Limb Dystonia) 12/2016 - 09/2015
1	Lewy Body Disease (Lewy Body Dementia) 01/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2020
1	Inflammation (Inflammations) 06/2020
1	Fatigue 01/2020
1	Retinal Degeneration 01/2019
1	Glaucoma 01/2019
1	Ganglion Cysts (Ganglion) 01/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Drug-Related Side Effects and Adverse Reactions 11/2018
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 11/2018
1	Schizophrenia (Dementia Praecox) 06/2018
1	Essential Tremor (Essential Tremors) 02/2018
1	Orthostatic Hypotension (Postural Hypotension) 12/2017
1	REM Sleep Behavior Disorder 10/2017
1	Anosmia 10/2017
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 12/2016
1	Hereditary Spastic Paraplegia 06/2015
1	Polyneuropathies (Polyneuropathy) 05/2013
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2013
1	Infections 02/2011
1	Fibrosis (Cirrhosis) 01/2009
1	Disease Progression 04/2008
1	Sialorrhea 12/2007
1	Parkinsonian Disorders (Parkinsonism) 12/2007
1	Nausea 12/2004
1	Tremor (Tremors) 12/2004
1	Vomiting 12/2004

Drug/Important Bio-Agent (IBA)

14	Apomorphine FDA Link 10/2021 - 09/2009
14	Levodopa (L Dopa)FDA LinkGeneric 10/2021 - 01/2003
9	Cholinergic Agents (Cholinergics)IBA 01/2022 - 12/2004
5	Pharmaceutical PreparationsIBA 01/2022 - 12/2004
5	Carbidopa (Lodosyn)FDA LinkGeneric 01/2020 - 02/2011
4	Rivastigmine (Exelon)FDA LinkGeneric 01/2014 - 12/2004
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2022 - 01/2003
3	Biomarkers (Surrogate Marker)IBA 06/2020 - 10/2017
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 04/2008
2	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 01/2020
2	fluoroethoxy-benzovesamicolIBA 06/2020 - 01/2019
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2011 - 08/2010
2	Dopamine Receptors (Dopamine Receptor)IBA 04/2008 - 01/2003
2	Dopamine Agents (Dopaminergic Agents)IBA 04/2008 - 01/2003
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2022
1	fluorodopa F 18IBA 06/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	Retinaldehyde (Retinal)IBA 01/2019
1	sodium metabisulfite (sodium pyrosulfite)IBA 11/2018
1	KetanserinIBA 06/2018
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 06/2018
1	Antihypertensive Agents (Antihypertensives)IBA 06/2018
1	Serotonin (5 Hydroxytryptamine)IBA 06/2018
1	Clozapine (Clozaril)FDA LinkGeneric 06/2018
1	hydroxide ionIBA 12/2017
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 10/2017
1	Baclofen FDA LinkGeneric 06/2015
1	SolventsIBA 06/2015
1	EndotoxinsIBA 11/2014
1	Coffee FDA Link 01/2014
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 05/2013
1	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 02/2011
1	Monoamine Oxidase (MAO)IBA 01/2010
1	rasagiline (Azilect)FDA Link 01/2010
1	Pergolide (Permax)FDA Link 01/2009
1	HomocysteineIBA 08/2008

Therapy/Procedure

14	Therapeutics 01/2022 - 04/2008
12	Deep Brain Stimulation 01/2022 - 12/2008
2	Subcutaneous Infusions 01/2018 - 01/2010
2	Activities of Daily Living (ADL) 01/2014 - 12/2004
1	Denervation 01/2021
1	Cognitive Training 01/2020
1	Dry Powder Inhalers 01/2019
1	Contraindications 01/2019
1	Transcranial Magnetic Stimulation 06/2018
1	Injections 12/2016
1	Home Nursing (Nursing, Home) 01/2012
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 02/2011
1	Radiotherapy 12/2007